Neurology · 2006 · 109 citations · 9 references
MedicineObstetricsPharmacologyEpilepsyHigh-risk PregnancyMaternal-fetal MedicineAntiepileptic PharmacologyCongenital Disorder EpidemiologyPerinatal PharmacologyPregnancyPregnancy PharmacologyPrenatal ToxicityCongenital Malformation RiskLevetiracetam TherapyLevetiracetam TreatmentLevetiracetam-based TherapyPharmacoepidemiology Of PregnancyPharmacotherapy During PregnancyPregnancy Management In EpilepsyPrenatal Neuropharmacology
It is not known whether the antiepileptic drug (AED) levetiracetam can be used safely in human pregnancy. As part of a study to determine the risks of major congenital malformations (MCMs) for infants exposed to AEDs in utero, we identified all cases exposed to levetiracetam. Three of 117 exposed pregnancies had an MCM (2.7%; 95% CI 0.9% to 7.7%); all 3 were exposed to other AEDs.
9
Birth Weight in Relation to Morbidity and Mortality among Newborn Infants
Donald D. McIntire, Steven L. Bloom, Brian M. Casey et al. · New England Journal of Medicine · 1999 · 1.3K citations
The Teratogenicity of Anticonvulsant Drugs
Lewis B. Holmes, Elizabeth A. Harvey, Brent A. Coull et al. · New England Journal of Medicine · 2001 · 659 citations · Full text
Medicine, Obstetrics, Pediatrics +17
Congenital malformations due to antiepileptic drugs
Shuji Kaneko, Dina Battino, E. Andermann et al. · Epilepsy Research · 1999 · 379 citations
Lamotrigine and the risk of malformations in pregnancy
Marianne Cunnington, Patricia Tennis · Neurology · 2005 · 350 citations